Work

Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis

Year: 2006

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428190600563821

Authors: Kristen N. Ganjoo, Caroline S. An, Michael J. Robertson, Leo I. Gordon, Joy A. Sen, Jill Weisenbach, Shuli Li, Edie A. Weller, Attilio Orazi, Sandra J. Horning

Institutions: Stanford Medicine, Stanford University, Indiana University Bloomington, Indiana University, Northwestern University, Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Society of Hematology, Genentech

OpenAlex ID: W2005575131

FWCI: 8.339

Cites: 39

Cited by: 102

Related to: 10